Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Effects of intensive blood-pressure control in type 2 diabetes mellitus.

ACCORD Study Group, Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F.

N Engl J Med. 2010 Apr 29;362(17):1575-85. doi: 10.1056/NEJMoa1001286. Epub 2010 Mar 14.

2.

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.

Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, MacMahon S, Turnbull F, Hillis GS, Chalmers J, Mant J, Salam A, Rahimi K, Perkovic V, Rodgers A.

Lancet. 2016 Jan 30;387(10017):435-43. doi: 10.1016/S0140-6736(15)00805-3. Epub 2015 Nov 7. Review.

PMID:
26559744
3.

Blood pressure targets for hypertension in people with diabetes mellitus.

Arguedas JA, Leiva V, Wright JM.

Cochrane Database Syst Rev. 2013 Oct 30;(10):CD008277. doi: 10.1002/14651858.CD008277.pub2. Review.

PMID:
24170669
4.
5.

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K.

Lancet. 2016 Mar 5;387(10022):957-67. doi: 10.1016/S0140-6736(15)01225-8. Epub 2015 Dec 24. Review.

PMID:
26724178
6.

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.

Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal TP, Hemmingsen C, Wetterslev J.

Cochrane Database Syst Rev. 2013 Nov 11;(11):CD008143. doi: 10.1002/14651858.CD008143.pub3. Review. Update in: Cochrane Database Syst Rev. 2015;(7):CD008143.

PMID:
24214280
7.

Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.

Blood Pressure Lowering Treatment Trialists' Collaboration, Ninomiya T, Perkovic V, Turnbull F, Neal B, Barzi F, Cass A, Baigent C, Chalmers J, Li N, Woodward M, MacMahon S.

BMJ. 2013 Oct 3;347:f5680. doi: 10.1136/bmj.f5680. Review.

8.

Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.

Emdin CA, Rahimi K, Neal B, Callender T, Perkovic V, Patel A.

JAMA. 2015 Feb 10;313(6):603-15. doi: 10.1001/jama.2014.18574. Review.

PMID:
25668264
9.

A Tale of 3 Trials: ACCORD, SPRINT, and SPS3. What Happened?

Krakoff LR.

Am J Hypertens. 2016 Sep;29(9):1020-3. doi: 10.1093/ajh/hpw065. Epub 2016 Jun 29. Review.

PMID:
27357398
10.

Interpreting SPRINT: How low should you go?

Thomas G, Nally JV, Pohl MA.

Cleve Clin J Med. 2016 Mar;83(3):187-95. doi: 10.3949/ccjm.83a.15175. Review.

Items per page

Supplemental Content

Write to the Help Desk